In this round-up of industry developments in China, we will look at beauty and nutrition consumption trends, how the country has become Asia’s probiotic powerhouse, and a new scientific research project linked to COVID-19.
The Therapeutic Goods Administration (TGA) will be conducting investigations on 12 artemisia species permitted for use in the country, following scientific reports on how intake of the botanical may lead to miscarriages.
Blackmores CEO Alastair Symington has told us the firm decided to sell its traditional Chinese medicine (TCM) and oriental botanical supplement arm Global Therapeutics amid a decline in the segments’ main retail channel – health food stores.
Phynova Group, the winner of the healthy ageing ingredient of the year award in this year’s NutraIngredients-Asia awards, says there are huge opportunities in Asia for glucose controlling products due to heightened consumer awareness.
Interest in plant-based omega-3 supplements is gathering momentum, according to Swisse and Vitality Wellness, as more evidence on how its unique omega-3, 6 ratios could lower cardiovascular disease risks and sustainability concerns arise.
A specialist doctor should also be an active clinical researcher in order to stay on top of the latest innovations and understanding, says the winner of NutraIngredients-Asia awards’ NutraChampion title.
Australian health and wellness company Eve Investments is launching its honey and tea tree oil sold under the brand Meluka Australia into more parts of APAC amid high growth in China on the back of consumer immunity concerns.